Sunshine Biopharma Inc. - Common stock · Transaction Jun 30, 2022 · Filed Jun 12, 2024 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · SBFM
-40.57% · -$0.2800 · Vol 118.5M
Market closed · last close 4:00 PM ET · price as of 19:59:39 ET
Sunshine Biopharma Inc
Biotechnology
$0.4160
Follow $SBFM
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $SBFM by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredThu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET · SBFM
MethodologySentiment absence reason unknown
SBFM
Sunshine Biopharma Inc
Thu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
45/ 100
Veridion Score
Middle range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Thu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is SBFM moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Sunshine Biopharma Inc
PHARMACEUTICAL PREPARATIONSListed since
2007
Employees
50
Country
US
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$0.4708
Day high
$0.4708
Day low
$0.3802
Previous close
$0.7000
52W high
$22.00
-98.11% from high
52W low
$0.3802
0% of range
Market cap
$2.7M
EPS
$-10.0329
Beta
0.89
Shares out
3.9M
Volume
118.5M
11.53× rel vol
Avg volume
10.3M
VWAP
$0.8009
Price history computed in-house
1W
-37.58%
1M
-62.86%
3M
-80.10%
1Y
-97.51%
YTD
-96.62%
SMA 50 $1.03 · below
SMA 200 $6.47 · below
52W position 0%
SBFM overview
Related filings and maps
Public disclosures
Congress activity in SBFM
1 filers · 1 buys · 0 sells (0 labeled S (partial)) · Jun 30, 2022 to Jun 30, 2022 · House 1 / Senate 0
All available history · Latest 1 of 1 lines · Read 2026-10-09T00:54:50.277Z
Official filing ↗
Federal contracts
SBFM contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for SBFM in this window.
Lobbying spend
SBFM lobbying filings, year to date.
Registered lobbying filings matched to Sunshine Biopharma Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for SBFM in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for SBFM.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.